Influence of ethanolic extract of Allium sativum on TP53 gene and its anticancer potential in N-Nitrosodiethylamine (NDEA)-induced hepatocellular carcinoma in male albino rats

Document Type : Original Article

Authors

Cancer Research and Infectious Disease Unit, Department of Cell Biology and Genetics, Faculty of Science, University of Lagos, Akoka, Lagos

Abstract

Objective(s): Cancer is a group of genetic disorders in which the behavior of the cell is disturbed by mutation and other abnormalities thereby posing as the leading cause of morbidity and mortality globally. Hepatocellular Carcinoma (HCC) is the most common form of liver cancer, highly aggressive with high mortality and incidence rate; and has limited therapeutic options. Most of the conventional cancer chemotherapeutics are associated with undesirable side effects, toxicity, chemoresistance, and high treatment cost, driving the need for a safer and more effective treatment alternative. Medicinal plants and herbs have shown very promising anti-cancer properties which are important for cancer treatment due to their multiple chemical compounds. 
Materials and Methods:  Qualitative screening of the ethanolic extractof Allium sativum was conducted showing the different phytochemicalspresent. The levels of liver function and hematological parameters wasdetermined via spectrophotometric analysis. Polymerase Chain Reaction techniquewas used to assess the gene patterns of Tumorsuppressor p53 (TP53).
Results: Phytochemical analysis revealed that Allium sativum has properties that antagonize the proliferating process of carcinogenesis in the liver. The NDEA-group showed significant distortion in the liver architecture characterized by vascular congestion of blood sinusoids, cirrhosis, and congestive hepatopathy while the treated groups showed a reduction in the abnormalities and malignant formation. The treated group showed a significant (P<0.05) increase and restored activities of Alanine aminotransferase (ALT), Aspartate aminotransferase (AST), Alkaline phosphatase (ALP), Bilirubin and hematological parameters (RBCs, WBCs, and Platelets). TP53 gene amplification was significantly (P<0.05) visible after treatment. 
Conclusion: Ethanolic plant extract of A. sativum demonstrates its anticancer properties by improving the liver architecture, increasing the antioxidant defense systems, and activation of the tumor suppressor (TP53) gene. Garlic extract has anti-proliferating properties and can be used as an alternative mode of treatment and prevention for hepatocellular carcinoma.

Keywords

References

1. Ohiagu FO, Chikezie CP, Chikezie CM, Enyoh CE. Anticancer activity of nigerian medicinal plants: a review. Future J Pharm Sci 2021; 7:1-21. 
2.    Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers 2021; 7:6-33.
3.    Sung H,  Ferlay J, Rebecca LS, Mathieu L, Isabelle S, Ahmedin J, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71:209-249.
4.    Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M. Global cancer observatory: Cancer today. Lyon: Intern Agency for Res on Canc. 
5.    Devarajan N, Jayaraman S, Mahendra J, Venkatratnam P, Rajagopal P, Palaniappan H, et al. Berberine-A potent chemosensitizer and chemoprotector to conventional cancer therapies. Phytother Res 2021; 35:3059-3077.
6.    Diwakar S, Akshatha NS, Divya P. Kumar etiology of hepatocellular carcinoma: special focus on fatty liver disease. Front Oncol 2020; 10:601710-601718. 
7.    Lane DP. Cancer p53, guardian of the genome. Nature 1992; 358:15–16.
8.    Levine AJ. P53: 800 million years of evolution and 40 years of discovery. Nat Rev Cancer 2020; 20:471–480. 
9.    Zhu G, Pan C, Jin-Xin B, Li B, Liang C, Xu Y, et al. Mutant p53 in cancer progression and targeted therapies. Front Oncol 2020; 10:595187-595195.
10.    Dehelean CA, Marcovici I, Soica C, Mioc M, Coricovac D, Iurciuc S, et al. Plant-derived anticancer compounds as new perspectives in drug discovery and alternative therapy. Molecules 2021; 26:1109-1137.
11.    Ali M, Ibrahim IS. Phytochemical screening and proximate analysis of garlic (allium sativum). Inorg Chem 2019; 4:478-482.
12.    Bhatwalkar SB, Mondal R, Krishna SBN, Adam JK, et al. Antibacterial Properties of Organosulfur Compounds of Garlic (Allium sativum). Front. Microbiol. 2021; 12:613077.
13.    Mughal MH. Garlic polyphenols: A diet based therapy. Biomed J Sci Tech Res 2019; 15:11453-11458.
14.    Thomson M, Ali M. Garlic [allium sativum]: A review of its potential use as an anti-cancer agent. Cur Canc D Targ 2003; 3:67-81.
15.    Amin A, Hamza A A, Bajbouj K, Ashraf SS, Daoud S. Saffron: a potential candidate for a novel anticancer drug against heptocellular carcinoma. Hepatol 2011; 54: 857-867
16.    Zaazaa AM, Lokman MS, Shalby AB, Ahmed HH, El-toumy SA. Ellagic acid holds promise against hepatocellular carcinoma in an experimental model: mechanisms of action. Asian Pac J Cancer Prev 2017; 19:387-393.
17.    Gonelimali FD, Lin J, Miao W, Xuan J, Charles F, Chen M, et al. Antimicrobial properties and mechanism of action of some plant extracts against food pathogens and spoilage microorganisms. Front Microbiol 2018; 9:1639-1647.
18.    Sofowora A. Screening plants for bioactive agents. In: Medicinal Plants and Traditional Medicinal in Africa. 2nd Ed. Spectrum Books Ltd, Sunshine House, Ibadan, Nigeria, pp. 1993; 134-156.
19.    Trease GE, Evans WC. Pharmacognosy. 15th Ed. Saunders Publishers, London. pp. 2002; 42-44, 221-229, 246-249, 304-306, 331-332, 391-393.
20.    Limdi JK, Hyde GM. Evaluation of abnormal liver function tests. Postgrad Med J 2003; 79:307–312.
21.    International Agency for Research on Cancer, World Health Organization. Cancer today. Available at: https://gco.iarc.fr/today/home.
22.    Khemlina G, Ikeda S, Kurzrock R. The biology of hepatocellular carcinoma: implications for genomic and immune therapies. Mol Cancer 2013; 16:149-158. 
23.    Villanueva A. Hepatocellular carcinoma. N Engl J Med 2019; 380:1450–1462. 
24.    Zhu RX, Seto WK, Lai CL, Yuen MF.  Epidemiology of hepatocellular carcinoma in the asia-pacific region. Gut Liver 2016; 10:332–339.
25.    Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: globocan sources and methods. Int J Cancer 2019; 144:1941–1953.
26.    Thylur RP, Roy SK, Shrivastava A, LaVeist TA, Shankar S, Srivastava RK. Assessment of risk factors, and racial and ethnic differences in hepatocellular carcinoma. JGH Open 2020; 4:351–359.
27.    Sagbo IJ, Otang-Mbeng W. Plants used for the traditional management of cancer in the eastern cape province of south africa: a review of ethnobotanical surveys, ethnopharmacological studies and active phytochemicals. Molcules 2021; 26:4639-4659.
28.    Mondal A, Sabyasachi B, Sankhadip B, Mazumder, S, Rebecca AH, Mohammad HF, et al. Garlic constituents for cancer prevention and therapy: from phytochemistry to novel formulations. Pharm Res 2021; 105837:1-90.
29.    Zhang Y, Liu X, Ruan J, Zhuang X, Zhang X, Zhiming L. Phytochemicals of garlic: promising candidates for cancer therapy. Biomed Pharmacother 2020; 123:1-7.
30.    Li Z, Le W, Cui Z.  A novel therapeutic anticancer property of raw garlic extract via injection but not ingestion. Cell Death Discover 2018; 4:108-117.
31.    Gopalakrishnan R, Sundaram J, Sattu K, Pandi A, Thiruvengadam D. Dietary supplementation of silymarin is associated with decreased cell proliferation, increased apoptosis, and activation of detoxification system in hepatocellular carcinoma. Mol Cell Biochem 2013; 377:163–176.
32.    Kujawska M, Ewertowska M, Adamska T, Ignatowicz E, Gramza-Michałowska A, Jodynis-Liebert J. Protective effect of yellow tea extract on N-nitrosodiethylamine-induced liver carcinogenesis. Pharmac Biol 2016; 54:1891-1900.
33.    Obakiro SB, Kiprop A, Kigondu E, K’owino I, Kiyimba K, Drago Kato C, et al. Sub-acute toxicity effects of methanolic stem bark extract of entada abyssinica on biochemical, haematological and histopathological parameters in wistar albino rats. Front Pharmacol 2021; 12:740305-740313.
34.    Awe EO, Banjoko SO. Biochemical and haematological assessment of toxic effects of the leaf ethanol extract of petroselinum crispum (mill) nyman ex A.W. hill (parsley) in rats. BMC Complement Altern Med 2013; 13:75–77.
35.    Mugisha MK, Ndukui JG, Namutembi A, Waako P, Karlson AB, Vudriko P. Acute and sub-acute toxicity of ethanolic leaf extracts of rumex abyssinica jacq. (polygonaceae) and mentha S picata L. (lamiaceae). Pharmacol Pharm 2014; 5:309–318. 
36.    Zaruwa MZ, Ibok NI, Ibok IU, Onyenonachi EC, Danchal C, Ahmed AG, et al. Effects of Sterculia setigera del. stem bark extract on hematological and biochemical parameters of wistar rats. Biochem Insights 2016; 9:19–22.
37.    Mwale M, Masika P, Materechera S. Effect of medicinal plants on haematology and serum biochemical parameters of village chickens naturally infected with heterakis gallinarum. Bangl J Vet Med 2014; 12:99–106.
38.    Lakin N, Jackson S. Regulation of p53 in response to DNA damage. Oncogene 1999; 18:7644–7655.
39.    Surget S, Khoury MP, Bourdon JC. Uncovering the role of p53 splice variants in human malignancy: a clinical perspective. Onco Targets Ther 2014; 7:57-68.
40.    Link T, Iwakuma T. Roles of p53 in extrinsic factor-induced liver carcinogenesis. Hepatoma Res 2017; 3:95-104.
41.    Villanueva A, Hoshida Y. Depicting the role of TP53 in hepatocellular carcinoma progression. J Hepatol 2011; 55:724–725.
42.    Yang C, Huang X, Li Y, Chen J, Lv Y, Dai S. Prognosis and personalized treatment prediction in TP53-mutant hepatocellular carcinoma: an in silico strategy towards precision oncology. Br Bioinformat 2021; 22:1-13.
Iranian Journal of Basic Medical Sciences
Volume 25, Issue 4
April 2022
Pages 497-505

Files

Share

How to cite

Statistics